SAG-MANNITOL SOLUTION 16.9 MG / 100 ML
ADENINE : 16.9 MG / 100 ML MANNITOL : 525 MG / 100 ML DEXTROSE ANHYDROUS : 818 MG / 100 ML SODIUM CHLORIDE : 877 MG / 100 ML · DIN 02421143 · LABORATORIOS GRIFOLS S.A.
Health Canada status: CANCELLED PRE MARKET
What is SAG-MANNITOL SOLUTION?
SAG-MANNITOL SOLUTION 16.9 MG / 100 ML contains ADENINE : 16.9 MG / 100 ML MANNITOL : 525 MG / 100 ML DEXTROSE ANHYDROUS : 818 MG / 100 ML SODIUM CHLORIDE : 877 MG / 100 ML. It is listed in the Health Canada Drug Product Database under DIN 02421143, held by LABORATORIOS GRIFOLS S.A., supplied as SOLUTION for 0-UNASSIGNED administration. Health Canada currently lists it as cancelled pre market, status dated 26-Jun-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02421143 |
|---|---|
| Brand name | SAG-MANNITOL SOLUTION |
| Generic / active ingredient | ADENINE : 16.9 MG / 100 ML MANNITOL : 525 MG / 100 ML DEXTROSE ANHYDROUS : 818 MG / 100 ML SODIUM CHLORIDE : 877 MG / 100 ML |
| Manufacturer | LABORATORIOS GRIFOLS S.A. |
| Strength | 16.9 MG / 100 ML |
| Dosage form | SOLUTION |
| Route of administration | 0-UNASSIGNED |
| Schedule | Ethical |
| ATC code | V07AD BLOOD TESTS, AUXILIARY PRODUCTS |
| AHFS class | 24:28.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 26-Jun-2022 |
What can be used instead?
Other Canadian products sharing ATC code V07AD BLOOD TESTS, AUXILIARY PRODUCTS. 0 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CPD SOLUTION | 2.63 G / 100 ML | SOLUTION | LABORATORIOS GRIFOLS S.A. | CANCELLED PRE MARKET | DIN 02421135 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.